These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 24095028)

  • 1. Genotype impact on HCV RNA levels determined with the VERSANT HCV RNA 1.0 assay (kPCR).
    Kessler HH; Hübner M; Konrad PM; Stelzl E; Stübler MM; Baser MH; Santner BI
    J Clin Virol; 2013 Nov; 58(3):522-7. PubMed ID: 24095028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of hepatitis C virus (HCV) genotypes on quantification of HCV RNA in serum by COBAS AmpliPrep/COBAS TaqMan HCV test, Abbott HCV realtime assay [corrected] and VERSANT HCV RNA assay.
    Tuaillon E; Mondain AM; Ottomani L; Roudière L; Perney P; Picot MC; Séguret F; Blanc F; Larrey D; Van de Perre P; Ducos J
    J Clin Microbiol; 2007 Sep; 45(9):3077-81. PubMed ID: 17581929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the new VERSANT HIV-1 RNA 1.0 Assay (kPCR) for quantitative detection of human immunodeficiency virus type 1 RNA.
    Troppan KT; Stelzl E; Violan D; Winkler M; Kessler HH
    J Clin Virol; 2009 Sep; 46(1):69-74. PubMed ID: 19576845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HCV RNA measurement in samples with diverse genotypes using versions 1 and 2 of the Roche COBAS® AmpliPrep/COBAS® TaqMan® HCV test.
    Pyne MT; Mallory M; Hillyard DR
    J Clin Virol; 2015 Apr; 65():54-7. PubMed ID: 25766989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the Roche COBAS AmpliPrep/COBAS TaqMan HCV Test.
    Pyne MT; Hillyard DR
    Diagn Microbiol Infect Dis; 2013 Sep; 77(1):25-30. PubMed ID: 23806661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analytical characteristics and comparative evaluation of Aptima HCV quant Dx assay with the Abbott RealTime HCV assay and Roche COBAS AmpliPrep/COBAS TaqMan HCV quantitative test v2.0.
    Worlock A; Blair D; Hunsicker M; Le-Nguyen T; Motta C; Nguyen C; Papachristou E; Pham J; Williams A; Vi M; Vinluan B; Hatzakis A
    Virol J; 2017 Apr; 14(1):66. PubMed ID: 28372576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus RNA quantitation in a nationwide French cohort of patients co-infected with HIV and HCV: should the same test be applied to all samples?
    Trimoulet P; Merchadou L; Winnock M; Loko MA; Fleury H; Salmon D; Dabis F; Neau D;
    J Virol Methods; 2012 Apr; 181(1):131-3. PubMed ID: 22285372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance evaluation of the new Roche cobas AmpliPrep/cobas TaqMan HCV test, version 2.0, for detection and quantification of hepatitis C virus RNA.
    Pas S; Molenkamp R; Schinkel J; Rebers S; Copra C; Seven-Deniz S; Thamke D; de Knegt RJ; Haagmans BL; Schutten M
    J Clin Microbiol; 2013 Jan; 51(1):238-42. PubMed ID: 23152551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical performance of the new rRoche COBAS TaqMan HCV Test and High Pure System for extraction, detection and quantitation of HCV RNA in plasma and serum.
    Gelderblom HC; Menting S; Beld MG
    Antivir Ther; 2006; 11(1):95-103. PubMed ID: 16518965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TaqMan amplification system with an internal positive control for HCV RNA quantitation.
    Castelain S; Descamps V; Thibault V; François C; Bonte D; Morel V; Izopet J; Capron D; Zawadzki P; Duverlie G
    J Clin Virol; 2004 Nov; 31(3):227-34. PubMed ID: 15465417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fully automated quantification of hepatitis C virus (HCV) RNA in human plasma and human serum by the COBAS AmpliPrep/COBAS TaqMan system.
    Sizmann D; Boeck C; Boelter J; Fischer D; Miethke M; Nicolaus S; Zadak M; Babiel R
    J Clin Virol; 2007 Apr; 38(4):326-33. PubMed ID: 17344093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of two Real-Time RT-PCR assays for quantitation of hepatitis C virus RNA: evaluation on HCV genotypes 1-4.
    Elkady A; Tanaka Y; Kurbanov F; Sugauchi F; Sugiyama M; Khan A; Ali EM; Mouhamed L; Abou el-fetouh S; AbdEl-Hameed AR; Mizokami M
    J Med Virol; 2010 Nov; 82(11):1878-88. PubMed ID: 20872714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the COBAS Hepatitis C Virus (HCV) TaqMan analyte-specific reagent assay and comparison to the COBAS Amplicor HCV Monitor V2.0 and Versant HCV bDNA 3.0 assays.
    Konnick EQ; Williams SM; Ashwood ER; Hillyard DR
    J Clin Microbiol; 2005 May; 43(5):2133-40. PubMed ID: 15872232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative evaluation between real time Roche COBas TAQMAN 48 HCV and bDNA Bayer Versant HCV 3.0.
    Giraldi C; Noto A; Tenuta R; Greco F; Perugini D; Spadafora M; Bianco AM; Savino O; Natale A
    New Microbiol; 2006 Oct; 29(4):243-50. PubMed ID: 17201090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the COBAS(®) AmpliPrep/COBAS(®) TaqMan(®) HCV Test, v2.0 and comparison to assays used in routine clinical practice in an international multicenter clinical trial: The ExPECT study.
    Kessler HH; Cobb BR; Wedemeyer H; Maasoumy B; Michel-Treil V; Ceccherini-Nelli L; Bremer B; Hübner M; Helander A; Khiri H; Heilek G; Simon CO; Luk K; Aslam S; Halfon P
    J Clin Virol; 2015 Jun; 67():67-72. PubMed ID: 25959162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of qualitative (COBAS AMPLICOR HCV 2.0 versus VERSANT HCV RNA) and quantitative (COBAS AMPLICOR HCV monitor 2.0 versus VERSANT HCV RNA 3.0) assays for hepatitis C virus (HCV) RNA detection and quantification: impact on diagnosis and treatment of HCV infections.
    Desombere I; Van Vlierberghe H; Couvent S; Clinckspoor F; Leroux-Roels G
    J Clin Microbiol; 2005 Jun; 43(6):2590-7. PubMed ID: 15956369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical evaluation of the COBAS Ampliprep/COBAS TaqMan for HCV RNA quantitation in comparison with the branched-DNA assay.
    Pittaluga F; Allice T; Abate ML; Ciancio A; Cerutti F; Varetto S; Colucci G; Smedile A; Ghisetti V
    J Med Virol; 2008 Feb; 80(2):254-60. PubMed ID: 18098148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of performances of VERSANT HCV RNA 1.0 assay (kPCR) and Roche COBAS AmpliPrep/COBAS TaqMan HCV test v2.0 at low level viremia.
    Mazzuti L; Lozzi MA; Riva E; Maida P; Falasca F; Antonelli G; Turriziani O
    New Microbiol; 2016 Jul; 39(3):224-227. PubMed ID: 27284986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analytical and clinical performance of the Hologic Aptima HCV Quant Dx Assay for the quantification of HCV RNA in plasma samples.
    Schønning K; Pedersen MS; Johansen K; Landt B; Nielsen LG; Weis N; Westh H
    J Virol Methods; 2017 Oct; 248():159-165. PubMed ID: 28732692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences between two real-time PCR-based hepatitis C virus (HCV) assays (RealTime HCV and Cobas AmpliPrep/Cobas TaqMan) and one signal amplification assay (Versant HCV RNA 3.0) for RNA detection and quantification.
    Vermehren J; Kau A; Gärtner BC; Göbel R; Zeuzem S; Sarrazin C
    J Clin Microbiol; 2008 Dec; 46(12):3880-91. PubMed ID: 18799708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.